Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ashe Andrew D.
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nickerson Joan
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ashe Andrew D.
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kathiresan Sekar
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nickerson Joan
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fiedorek Fred T.
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dorval Allison
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bellinger Andrew
Verve Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.81%)
Verve Therapeutics | 5: Annual statement of changes in beneficial ownership of securities-Director ADELMAN BURT A
Verve Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)
Verve Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARK Investment Management LLC(8.74%)
Verve Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(4.81%)
Verve Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-XXVI Holdings Inc.(15.4%),Alphabet Inc.(15.4%), etc.
Verve Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(4.842%),Abigail P. Johnson(4.842%)
Verve Therapeutics | 3: Initial statement of beneficial ownership of securities-Other GV 2023 GP, L.L.C.
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Yeshwant Krishna
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Dorval Allison
Verve Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fiedorek Fred T.
Verve Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Fiedorek Fred T.
No Data